Clinical Intake — Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

A 38-year-old male with focal epilepsy diagnosed in 2019 presents with persistent seizures characterized by impaired awareness, occurring 3–4 times per month despite optimized pharmacotherapy. He was initiated on levetiracetam approximately 18 months ago with partial reduction in seizure frequency from roughly 6 to 3–4 episodes per month; breakthrough events continue despite a confirmed therapeutic serum level documented in January 2026. Electroencephalography performed in November 2025 identified left temporal interictal epileptiform discharges, while brain neuroimaging from October 2025 was unremarkable. Dr. Kapoor refers the patient for specialist evaluation of additional treatment options given continued seizure burden on current antiseizure therapy.